Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction)
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Open-label single center study of duloxetine in patients with SOD who have failed to respond
to the standard treatments.
This protocol is designed to explore the tolerability and efficacy of Duloxetine in the
management of patients with known or suspected Sphincter of Oddi dysfunction (SOD).